Intimation for the Closure of Trading Window in terms of SEBI (Prohibition of Insider Trading) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Ltd has informed the BSE that the trading window for its equity shares will remain closed for insiders starting Thursday, January 1, 2026. The closure will end 48 hours after the company announces its unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2025. During this period, designated persons and their immediate relatives are prohibited from buying or selling the company's shares. The company will also freeze the PANs of these insiders at the CDSL depository portal in line with SEBI guidelines. The actual date of the board meeting to approve these Q3 results will be communicated later.
This is a routine regulatory filing required under SEBI's insider trading rules ahead of the company's quarterly results. It has no direct impact on the stock price but signals that Q3 FY26 earnings announcement is expected in January 2026, which investors should watch for.